摘要
观察了54例肺心病肺动脉高压症病例,中药组血二氧化碳分压(PaCO_2)明显减低,血氧分压(PaO_2)和动脉血氧饱和度(SaO_2)升高,心率(HR)、心输出量(CO)、肺动脉平均压(mPAP)和肺血管阻力(PVR)降低(P<0.05)。中、西药组比较,mPAP、PVR差异无显著性(P>0.05),体循环收缩压(SBP)差异有显著性(P<0.05)。临床观察表明,复方葶苈注射液具有降低mPAP,改善动脉血气分析指标的作用,且对体循环压力无影响。经过一个疗程的治疗后,患者的症状、体征较治疗前好转,中药组有效率89.3％。
In 54 cases of pulmonary hypertension, the PaCO2 was markedly lowered, PaO2 and SaO2 elevated, HR, CO and mPAP, PVR all lowered in the treatment group (P<0. 05). When compared with the group treated by western drugs, there was no difference in mPAP. PVR (P>0. 05), but SBP was significantly different (P< 0. 05). Clinically, the Lipidium Co. Injection yielded the actions of lowering mPAP, improving arterial gas analysis, with no effect on general circulation. Patients' signs, symptoms, were all improved after 1 month treatment, with an effective rate of 89. 29% for the TCM group.
出处
《中医杂志》
CSCD
北大核心
1999年第4期225-226,共2页
Journal of Traditional Chinese Medicine
